The Beckwith -Wiedemann syndrome (BWS) is a growth disorder for which an increased frequency of monozygotic (MZ) twinning has been reported. With few exceptions, these twins are discordant for BWS and for females. Here, we describe the molecular and phenotypic analysis of 12 BWS twins and a triplet; seven twins are MZ, monochorionic and diamniotic, three twins are MZ, dichorionic and diamniotic and three twins are dizygotic. Twelve twins are female. In the majority of the twin pairs (11 of 13), the defect on chromosome 11p15 was hypomethylation of the paternal allele of DMR2. In 5 of 10 twins, there was additional hypomethylation of imprinted loci; in most cases, the loci affected were maternally methylated, but in two cases, hypomethylation of the paternally methylated DLK1 and H19 DMRs was detected, a novel finding in BWS. In buccal swabs of the MZ twins who share a placenta, the defect was present only in the affected twin; comparable hypomethylation in lymphocytes was detected in both the twins. The level of hypomethylation reached levels below 25%. The exchange of blood cells through vascular connections cannot fully explain the degree of hypomethylation found in the blood cell of the non-affected twin. We propose an additional mechanism through which sharing of aberrant methylation patterns in discordant twins, limited to blood cells, might occur. In a BWS-discordant MZ triplet, an intermediate level of demethylation was found in one of the non-affected sibs; this child showed mild signs of BWS. This finding supports the theory that a methylation error proceeds and possibly triggers the twinning process.
Beckwith and Wiedemann
1,2 reported a syndrome of macroglossia and omphalocele, associated with adrenal cortical cytomegaly, fetal gigantism and other abnormalities. The Beckwith -Wiedemann syndrome (BWS) is thus characterized by overgrowth during fetal development and, as subsequently documented, a markedly increased susceptibility to certain childhood tumours. 3 -6 Two imprinted gene clusters on chromosome 11p15.5 are involved in the aetiology of BWS. The more telomeric cluster (BWSIC1) contains the embryonal growth factor IGF2 and a non-coding RNA, H19, expressed from the paternally and maternally derived alleles, respectively. Parentally restricted expression of the genes in this cluster is regulated through an imprinting centre (IC1) that contains a differentially methylated region, DMR1 (DMRH19), located within the promoter of H19. The more centromeric cluster, under the control of imprinting centre 2 (BWSIC2), contains the cell cycle inhibitor CDKN1C and an antisense RNA, KCNQ1OT1. Expression of these genes is regulated by a maternally methylated imprinting centre (IC2) containing a DMR (DMR2 or KvDMR) located within KCNQ1 (see Figure 1 ).
Among BWS patients, different genetic and epigenetic lesions of 11p15 have been detected. In the majority of patients, an imprinting defect is present: 55% of patients manifest loss of maternal methylation of DMR2, and 5% have gain of methylation of DMR1 on the maternal chromosome. In 20% of the patients, genetic defects of 11p15 such as uniparental disomy, translocations and trisomies have been detected, and 5% of the patients have loss of function mutations in CDKN1C; in the remaining patients, the cause of disease remains unknown. 7 -10 In a subset of BWS patients (20%) with an imprinting defect of DMR2, an additional loss of methylation has been detected at other imprinted loci throughout the genome, including PLAGL1, NESPAS, PEG3, IGF2R, SNRPN and GRB10. 11, 12 Hypomethylation of multiple maternally methylated imprinted loci, including KCNQ1OT1, was also described in patients with transient neonatal diabetes. 13 Phenotypic discordance between monozygotic (MZ) ('identical') twins is a well recognized though incompletely understood phenomenon. MZ twins occur in the population at a rate of 3 -4 per 1000 births and at a sex ratio approximating 1:1, although female twinning is more prevalent in later twinning events.
14 MZ twins derive from a single zygote and therefore should have, in theory, identical genomes, apart from somatically acquired (epi)-mutations. However, many examples of genetic differences between MZ twins have been reported, 15 -18 indicating that these somatic changes may occur soon after conception. MZ twinning occurs in a time frame spanning 4 -9 days after conception, and the developmental stage of twinning is indicated by the resultant placentation of the twins. Twenty-five percent/one-third of MZ twins have separate placentas; dichorionic MZ (DC-MZ) twinning is postulated to occur 0 -4 days after fertilisation, before the formation of the blastocyst. Monochorionic monzygotic (MC-MZ) twins result from twinning events approximately 44 days after fertilisation, after the chorion is formed and therefore share a placenta. The majority of MC-MZ twins have separate amniotic membranes (diamniotic); in the rare cases where twinning occurs relatively late (o5%), the twins also share a single amniotic sac.
By contrast, with MZ twins, dizygotic (DZ) twinning occurs when two oocytes mature and become fertilised by two different sperm cells at the same time. DZ twins have equivalent genetic concordance to siblings. The frequency of dizygotic twinning is about 9 -20 per 1000 live births in Europe and the sex ratio approximates 1:1.
19 DZ twins have separate placentas and amniotic membranes, although occasionally the placentas can be fused and vascular connections may be present. Several monochorionic dizygotic twins have been reported, almost exclusively cases of assisted reproduction (ART). 20 In the literature, a large number of BWS twins have been described. Remarkably, the great majority of BWS twins are MZ, but they are discordant, that is, one twin presents with BWS, whereas the other is unaffected (though an unaffected twin may have some features of the disease). Moreover, the majority of BWS twins show hypomethylation of DMR2. There is a striking excess of female twins, suggesting a possible mechanistic link with X-chromosome inactivation. 21 Machin 22 hypothesized that discordancy of XI in MZ twinning may result from mutual repulsion of cell clones with different XI. Bestor 23 further proposed that the failure of DNA methylation maintenance in a single cell in early zygotic development could introduce epigenetic and hence functional asymmetry into the zygote, and potentially precipitate a twinning event. The molecular basis of this failure is thought to be a Dmnt1o defect, occurring at an Other genetic defects have been found in BWS twins: 25 uniparental disomy in a male MZ twin pair 26 and a mosaic trisomy 11p15 in a female MZ twin pair. 27 In the majority of BWS cases, molecular diagnosis relies on analysis of leukocyte-derived DNA. In two large studies, 24, 28 DMR2 hypomethylation was found in DNA derived from blood samples of both the affected and nonaffected twins of discordant twin pairs. It has been proposed that aberrant methylation in the blood of the healthy twin is caused by vascular connections in the placenta that is shared by both MZ (monochorionic, diamnionic) twins. 24 In this study, we describe the epigenetic and phenotypic analysis of 13 discordant BWS twin pairs, including DZ, DC-MZ and MC-MC pairs. We determined the nature and frequency of their epigenetic defects at 11p15 and at other imprinted loci, and we investigated whether vascular connections could account for the epigenetic anomalies seen in healthy twins of discordant BWS.
Materials and methods
Most twins were referred to our laboratory for routine diagnostic screening for BWS. Twin 7 is described by 27 and twin 8 was referred to us by Dr LM Yates, Newcastle on Tyne, UK, for research purposes. DNA was extracted from blood lymphocytes, buccal swabs and/or saliva. Clinical data were obtained by sending questionnaires to referring paediatricians. Data on placentation were obtained, when available, from the original pathological report of the placenta. Birthweight centiles were calculated according to Gielen et al. 29 Zygosity was established with the use of PowerPlex 16 (Promega Corporation, Madison, WI, USA). Zygosity testing was performed on DNA isolated from buccal swabs when available; in all other cases, it was performed on DNA isolated from blood lymphocytes. Methylation analysis of DMR1 and DMR2 were performed either by southern blot analysis, as described earlier, 9 or by HRMA as described by
Alders et al 30 and MS-PCR as described earlier. 13 Analysis of loci other then chromosome 11p15 was performed by MS-PCR. X-chromosome inactivation was performed as described by Allen et al 31 and calculated according to
Horsthemke et al.
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Results
Zygosity, placentation and female-to-male ratio The findings concerning zygosity, placentation and femaleto-male ratios are summarised in Table 1 .
The rate of MZ twinning is increased among BWS patients. Our diagnostic laboratory received 13 BWS twin pairs (12 twins and one triplet) among 400 BWS patients referred for routine diagnostic screening. The dizygotic twinning rate was normal compared with the normal population (0.75 (3 of 400) vs 0.70 -1.1%). The MZ twinning rate was increased, with a frequency of 2.5% (10 of 400) as compared with 0.3 -0.4% among normal twins. 24, 33 The distribution of monochorionic and dichorionic twins among MZ twins was similar to that in the normal population. Placentation was known in two out of the three dizygotic twins in this study. They were both conceived by ART (1 Â ovulation induction, 1 Â IVF). Both cases showed separate placentas. All the three DZ twins were female, and 9 of 10 MZ twins were female. Although the numbers are small, this differs from what is observed among normal twins where there is a very small shift towards females (0.496 -0.512 33 ) and is consistent with the findings of Weksberg et al.
(Epi) genotype
The methylation profiles of all twins are summarised in Table 2 . In 11 of 13 cases, the (epi) genetic defect was hypomethylation of the maternal DMR2 (KCNQ1OT1). In one case (twin 7), a mosaic trisomy of chromosome 11p was found to result in an increased methylation level of DMR1 (H19) and a decreased methylation level of DMR2 (KCNQ1OT1). In one case (twin 12), there was no detectable genetic defect. A CDKN1C mutation was excluded in these twins.
In six of the seven MZ twins who shared a placenta (MZ MC-DA), demethylation of DMR2 could be detected in the blood of both the affected and the non-affected twin. In buccal swabs, the defect was present only in the twin with the BWS phenotype in five twins (Figure 2a) . A different situation is present in the triplet 3A -3C (Figure 2b ). The affected sib (3A) showed a similar degree of hypomethylation in DNA from the buccal swab and from the blood. The second sib (3B) also showed aberrant methylation in her buccal swab, but at a lower level than in her blood. No loss of methylation could be detected in the third sib (3C). Blood samples of the triplet were taken with a 6-year interval. Methylation levels are comparable between the two samples taken from each twin, and also comparable with DNA from saliva of all three sibs. The tongue of twin 3A was surgically reduced, and DNA isolated from this material showed an equal level of LOM compared with lymphocyte DNA.
In the remaining MZ twin who shared a placenta (twin 7), the percentage of trisomic cells was determined in the blood and fibroblasts of both twins. 27 In the blood of both twins, 50% trisomic cells were detected, whereas they were absent in fibroblasts of the non-affected twin. In all (6 of 6) twins, both MZ and DZ, with separate placentas, the demethylation of DMR2 was detected only in the blood of the affected child. An exception was twin 10, in whose case mild demethylation was found in the affected twin, and more severe demethylation was detected in the non-affected twin.
Methylation on loci outside the 11p15 region was analysed in 10 of 13 twins in this study. In 50% (5 of 10), hypomethylation of at least one other imprinted locus was detected (4 of 6 MZ MC-DA, 0 of 2 MZ DC-DA and 1 of 2 DZ).
In two cases (twin 2 and twin 11), a modest degree of demethylation of two paternally imprinted genes, H19 and DLK1, was observed. The decreased methylation level of H19 was detected both by HRMA and MS-PCR (see Figure 2c and d) . In both twins, the H19 region analysed by HRMA was sequenced, revealing no SNPs in the fragment.
The levels of demethylation were comparable between the sibs of each twin pair at all loci analysed.
In addition, the methylation levels of DMR2 were also studied in the saliva of twins A, D and J. They showed, as in blood, demethylation of DMR2 in both the affected and non-affected twin.
The level of X-chromosome inactivation was determined in twins A, F and M. The inactivation levels of both twins were almost identical (A1: 79%; A2: 74%, F1: 73%, F2: 69%; M1: 79%, M2: 64%) and not skewed.
Phenotype
The phenotypic data of the BWS twins are summarised in Supplementary Table 3 .
All twins, DZ and MZ, were discordant for clinical manifestations typical for BWS. Although in almost all cases the genetic defect is demethylation of DMR2, relative birthweight centiles were calculated for or against twin referents.
29 Of the three major criteria, macrosomia (birthweight above birth weight centile P9), macroglossia and abdominal wall defects, macrosomia was present only in 5 of the 11 affected twins (twins 6, 7, 11 and 13). In 4 of 10 cases, the unaffected twin had a higher birthweight compared with the affected twin (twins 1, 3B, 9 and 10). Macroglossia was present in 10 of 11 twins, whereas in 9 of 11 cases an abdominal wall defect was present (in most cases, an umbilical hernia). In two twins (twins 5 and 7), the twin-to-twin-transfusion syndrome (TTTS) was observed, with the affected twin as recipient and the unaffected twin as donor. In many of the twins, the duration of the pregnancy was shorter than the average for normal twins (37 weeks 29 ). In three out of six twins (twins 1, 2 and 3) with complex demethylation, the duration was o33 weeks, and the twin with trisomy was also born preterm (30 weeks).
In four MZ MC-DA twins, some signs of BWS were present in the non-affected twin: twin 2B had an abdominal wall defect (umbilical hernia) and hypoglycaemia at birth, twin 3B had macrosomia and mild macroglossia, whereas both twins 3B and 3C had hypoglycaemia, twin 5B also showed hypoglycaemia and twin 6B had an abdominal wall defect (umbilical hernia). None of the non-affected twins fulfilled the clinical criteria for BWS.
Discussion
This study extends our current understanding of the relationship between MZ twinning, early developmental processes and epigenetic disorders. We confirm earlier observations that MZ twinning rates are increased among BWS patients and that BWS MZ twins are predominantly discordant and frequently female. However, our observations present some challenges to current hypotheses about the mechanisms and consequences of DMZ twinning.
Excess of twins and females in BWS patients
In our cohort, we identified 13 twin pairs (12 twin pairs and one triplet) among 400 BWS patients (3%): three were DZ (0.8%), a frequency similar to that in the normal population, whereas 10 were MZ, or 2.3% compared with 0.3% in the normal population. The excess of MZ twins among BWS patients with DMR2 hypomethylation suggests that the methylation defect and the twinning process are correlated. All the MZ BWS twins were diamniotic, suggesting that the shared causative event occurred at approximately days 4 -9 of zygotic development.
This study also confirms the excess of females among BWS multiple births, as 12 of the 13 twins described were females. This female excess might be related to X-chromo- Lessons from BWS twins J Bliek et al some inactivation, twinning, BWS or all of these. Similar to Weksberg et al, 24 we found no evidence for a specific association between skewed X-chromosome inactivation and BWS among our MZ twins. It is possible that the biological mechanisms of X-chromosome inactivation interfere or interact with the maintenance of methylation at the autosomal imprinted loci. However, as X-chromosome inactivation occurs only in females, and some male MZ twins discordant for BWS have been described, the process of X-chromosome inactivation itself cannot be the only factor affecting the methylation of the BWS locus.
Excess of LOM of DMR2 in BWS twins
In the majority of twins (11 of 13), a methylation defect of DMR2 could be detected, supporting the theory of Bestor 23 that a failure of methylation maintenance results in twinning and a methylation defect in the affected twin. This failure is thought to occur at the eight-cell blastocyst stage, preceding the moment that MZ MC DA twinning takes place (days 4 -9). However, Bestor's theory 23 raises the question why not all methylation defects result in twinning, whereas the majority of the BWS cases are singletons. An explanation might be that twinning did occur in all cases, but that the second fetus was resorbed early in pregnancy (vanishing twin, reviewed by Landy and Keith 34 ).
In one case (twin 12), the genetic cause is unknown, whereas the genetic cause of BWS in twin 7 is trisomy 11p15. The latter case is not a methylation defect as such, but was probably caused by a mitotic non-homologous recombination event. That is also observed by O'Donnell et al 35 in a twin discordant for trisomy 21 and by Rohrer et al 36 in a twin discordant for the Turner's syndrome.
Excess of HIL in twins
This study shows for the first time that a subset of discordant MZ twins with BWS manifest hypomethylation of multiple imprinted loci (HIL). This multiple hypomethylation has been described in B25% of patients with BWS caused by hypomethylation of DMR2, 11 Bliek et al, 2008).
The HIL in this cohort differs from the earlier studies in two respects: first, it was present in four of the seven twins of whom material was available, and second, it affected not only maternally methylated loci but also paternally methylated loci, H19 and DLK1. It remains to be seen whether it has a different underlying biology from that seen in singleton BWS cases, or whether a genetic cause exists such as the mutation of ZFP57 seen in some patients with transient neonatal diabetes and HIL. 37 Presence of anomaly in blood and not (generally) in buccal cells of unaffected twin Part 1: anomaly present in blood of both twins In all twins with shared placentation in leukocyte DNA, aberrant methylation was found in both the affected twin and the healthy twin. As 70% of all MZ monochorionic twins share blood through vascular connections, 19 it is generally postulated that the aberrant methylation found in the blood of the unaffected twin results from fetal circulation sharing through shared blood vessels in the placenta. This exchange includes the exchange of haematopoietic stem cells (HSCs) present in circulating blood. 16, 35 However, for two reasons this theory does not explain the observation that an equivalent and severe hypomethylation was detected in leukocyte DNA of both the affected and unaffected twins.
First, even in a case of complete hypomethylation in an affected twin, circulation sharing would be expected to result in an apparent twofold hypomethylation in the blood of both twins (see Supplementary Figure 3) . In this study, the twins 1, 3, 4 and 6 show methylation levels indicating the presence of more than 75% aberrant lymphocytes in the blood of both the affected and nonaffected twins. This is also observed in other studies. 24 Second, as the fraction of aberrant cells is about equal in both twins, the HSC pool is expected to be identical. The exchange of the entire HSC population through vascular connections seems unlikely, as the majority of the HSCs home early in development to either the spleen or the liver and in a later stage to the bone marrow (see Supplementary Figure 4) . Therefore, the severe hypomethylation sometimes seen in the blood of both twins may derive not merely from circulation sharing, but rather from a common source of HSCs with aberrant methylation.
The first signs of blood cell and vessel formation (angiogenesis and vasculogenesis) are found in the mesoderm of the yolk sac (reviewed by Oostra et al 38 ) .
The yolk sac is an early discernible structure in embryonic development, the anlage of which is formed during the second week of gestation in the human embryo. It faces the lower surface of the embryonic disk, comparable to the amnion, which faces the upper surface. The first phase of gastrulation is characterized by the formation of the extraembryonic mesoderm, which covers both the amnion and the yolk sac membranes. Subsequently, part of the yolk sac epithelium facing the embryonic disc, called hypoblast, is replaced by endoderm. In a later stage when the embryonic disk starts to fold, this part of the yolk sac is incorporated in the embryonic body and will give rise to the intestinal tract and parts of the urogenital system. It is no surprise that the first HSCs appear in the yolk sac mesoderm, as in all non-placental vertebrates the contents of the yolk sac are the only source of nutrients to the developing embryo, the use of which requires a circulatory system. Up to recently, it was assumed that adult HSCs originate from the embryonic aorta-mesonephros-gonad (AMG) region and that the HSC precursors found in the yolk sac only serve the gastrulating embryo (reviewed by Ueno and Weissman 39 Lessons from BWS twins J Bliek et al from yolk sac precursors, at least partially. In view of our hypothesis that BWS twins share a common HSC source, one could imagine that the twinning process itself starts after the origin of this source, that is, the extra-embryonic mesoderm covering the yolk sac has formed. Although this seems conceivable only for monoamniotic twinning, the presence of a single yolk sac on ultrasound investigations in monochorionic diamniotic human twin pregnancies (as represented in Figure 3 ) has been reported to occur to such a degree that it is discouraged to use the number of yolk sacs to determine amnionicity. 41 This hypothesis, that the affected and non-affected twin share a common yolk sac, does not explain the fact that these aberrant cells account for more than 75% of all lymphocytes in both the affected and non-affected twin. That can be explained only if the yolk sac was derived from the affected twin. Another option, that HSCs with a methylation defect have a growth advantage over the normal cells and therefore replace the normal cell in the HSC pool, is not likely because methylation studies performed at different time points in BWS patients show stable methylation levels during life (see twin 3 in Figure 2b and DJ Mackay, unpublished results). It cannot be excluded that HSCs have a growth advantage only during a certain stage of development and not after birth. It should also be noted that DNA derived from saliva samples primarily contain leukocyte DNA, and therefore, similar to blood-derived DNA, cannot be used to distinguish discordant twins. Genetic testing in these cases should be performed on other tissues such as buccal swabs.
Presence of anomaly in blood and not (generally) in buccal cells of the unaffected twin Part 2: anomaly not (normally) in buccal cells of unaffected twin We observed that in twins with shared placentation, imprinting anomalies seen in leukocyte DNA of both twins were generally seen in buccal swab DNA of only the unaffected twin. In the triplets that shared a single placenta, LOM of DMR2 was detected in DNA isolated from buccal swabs from the affected (3A) and the mildly affected twin (3B). Triplet 3A had similar levels of LOM in blood and buccal swab DNA, whereas triplet 3B showed milder hypomethylation in buccal swab than in blood. Buccal swab DNA from 3C showed normal methylation.
The presence of a methylation defect in two out of three triplets indicates that it must have arisen before the splitting of the zygote; the unequal methylation defect in the affected triplets suggests an unequal distribution of aberrant cells in the twinning process. This supports the theory of Bestor 23 that the methylation defect precedes and possibly triggers the twinning event. The BWS features in triplet 3B may result from the small population of methylation-defective cells in this individual.
Imperfect phenotypic discordance: cause is either low level of aberrant cells or altered gene expression transferred through circulation No twins in our series were concordant for BWS, but in 4 of 10 MZ cases, signs of BWS such as macrosomia, abdominal wall defects, macroglossia and hypoglycaemia were seen in healthy twins. This was also observed in earlier case reports. The unaffected twin of an MZ pair described by Clayton-Smith 43 showed macroglossia, naevus flammeus and earlobe creases. 42, 43 In another MZ twin pair, 21 the unaffected twin showed a small umbilical hernia, and transient neonatal macroglossia and naevus flammeus were observed by Olney 42 in a further unaffected MZ twin.
In none of these three cases was the aetiology of disease established. By contrast, Smith 26 described a twin pair with DMR1 hypermethylation who were concordant but showed minor phenotypic differences, twin A presenting with umbilical hernia and twin B with naevus flammeus.
The BWS features present in less-affected twins may, similar to those in the triplets 3A -3C, be explained by a low level of mosaicism in certain tissues of these individuals. Possibly, the number of aberrant cells in the buccal swabs of these individuals does not reach the detection levels of the methylation test. It is also possible that less-affected twins do not harbour cells with methylation defects, except in their circulation. Their BWS features may be caused by altered expression in the circulation of genes controlled by DMR2.
In conclusion, we have confirmed the prevalence of MZ twins with discordant presentation and of female twins among BWS patients. We have shown that 5 of 10 discordant MZ BWS twins have a generalized hypomethylation of imprinted genes -including, uniquely, paternally methylated loci -throughout the genome. We show that methylation patterns and phenotypes of a BWS triplet support the theory that methylation failure precedes and possibly triggers the twinning process. We propose a mechanism, involving migration of the blood cell precursor cells from the yolk sac to both twins, to explain similar aberrant methylation found in blood cells of discordant twin pairs.
